Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (61-70 of 426) with videos related to

Pageof 43
Sort By:
The Journal of Experimental Medicine|April 1, 1970
Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9P J Lachmann, R A Thompson
Radiation Research|October 1, 1989
Hyperthermia, polyamine depletion, and inhibition of X-ray-induced DNA strand break repairR D Snyder, P J Lachmann
Advances in Chronic Kidney Disease|August 28, 2012
The role of immunological assessment in patients with acute kidney injury and possible myelomaHelen J Lachmann, Nancy L Wassef
Indian Journal of Pediatrics|January 30, 2016
Autoinflammatory Syndromes in ChildrenRuth J Pepper, Helen J Lachmann
European Journal of Immunology|November 22, 1997
Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexesJ K Voice, P J Lachmann
Nephron. Clinical Practice|September 16, 2003
Novel pharmacological strategies in amyloidosisHelen J Lachmann, Philip N Hawkins
Clinical and Experimental Immunology|December 1, 1982
In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complementN T Gorman, P J Lachmann
Chronic Respiratory Disease|December 28, 2006
Amyloidosis and the lungH J Lachmann, P N Hawkins
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Pageof 43

Showing results (61-70 of 426) with videos related to

Sort By:
Pageof 43
The Journal of Experimental Medicine|April 1, 1970
Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9P J Lachmann, R A Thompson
Radiation Research|October 1, 1989
Hyperthermia, polyamine depletion, and inhibition of X-ray-induced DNA strand break repairR D Snyder, P J Lachmann
Advances in Chronic Kidney Disease|August 28, 2012
The role of immunological assessment in patients with acute kidney injury and possible myelomaHelen J Lachmann, Nancy L Wassef
Indian Journal of Pediatrics|January 30, 2016
Autoinflammatory Syndromes in ChildrenRuth J Pepper, Helen J Lachmann
European Journal of Immunology|November 22, 1997
Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexesJ K Voice, P J Lachmann
Nephron. Clinical Practice|September 16, 2003
Novel pharmacological strategies in amyloidosisHelen J Lachmann, Philip N Hawkins
Clinical and Experimental Immunology|December 1, 1982
In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complementN T Gorman, P J Lachmann
Chronic Respiratory Disease|December 28, 2006
Amyloidosis and the lungH J Lachmann, P N Hawkins
Sub-Cellular Biochemistry|December 11, 2012
Systemic AA amyloidosisJennifer H Pinney, Helen J Lachmann
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Pageof 43